PAR — Par Drugs and Chemicals Balance Sheet
0.000.00%
- IN₹1.27bn
- IN₹1.08bn
- IN₹956.40m
Annual balance sheet for Par Drugs and Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | Interim Report | ARS | ARS | ARS |
Standards: | IAS | — | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 73.8 | 212 | 162 | 222 | 367 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 139 | 125 | 217 | 212 | 185 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 242 | 412 | 436 | 494 | 596 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 351 | 344 | 344 | 387 | 413 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 601 | 764 | 787 | 889 | 1,016 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 108 | 160 | 149 | 140 | 124 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 195 | 242 | 188 | 176 | 160 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 406 | 522 | 599 | 712 | 856 |
Total Liabilities & Shareholders' Equity | 601 | 764 | 787 | 889 | 1,016 |
Total Common Shares Outstanding |